InvestSMART

Pacific Smiles Group Limited (ASX: PSQ) - Announcements

DELISTED - Current share price for PSQ : $2.180

ASX company news and announcements for Pacific Smiles Group Limited (PSQ) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Pacific Smiles Group Limited (PSQ) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Pacific Smiles Group Limited (PSQ), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Pacific Smiles Group Limited (PSQ)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Dividend/Distribution - PSQ 19 Jul 2024 9:42AM $1.800 $2.180 risen by 21.11%
- Decision regarding Permitted Dividend 19 Jul 2024 9:35AM $1.800 $2.180 risen by 21.11%
- Ceasing to be a substantial holder from MUFG 18 Jul 2024 4:14PM $1.800 $2.180 risen by 21.11%
- Notice of Second Court Hearing 18 Jul 2024 8:58AM $1.800 $2.180 risen by 21.11%
- Update on treatment of incentives under Scheme 18 Jul 2024 8:54AM $1.800 $2.180 risen by 21.11%
- Ceasing to be a substantial holder from MS 17 Jul 2024 5:56PM $1.800 $2.180 risen by 21.11%
- Becoming a substantial holder from MUFG 16 Jul 2024 10:50AM $1.840 $2.180 risen by 18.48%
- Notification of cessation of securities - PSQ 15 Jul 2024 5:07PM $1.840 $2.180 risen by 18.48%
- Update on Genesis Capitals voting intentions 15 Jul 2024 8:43AM $1.840 $2.180 risen by 18.48%
- Becoming a substantial holder from MS 12 Jul 2024 5:20PM $1.840 $2.180 risen by 18.48%
- Update on Takeovers Panel proceedings 11 Jul 2024 9:13AM $1.845 $2.180 risen by 18.16%
- TOV: PSQ - Panel Declines to Make Orders 5 Jul 2024 11:22AM n/a $2.180 n/a
- Dispatch of Scheme Booklet 1 Jul 2024 12:00PM $1.890 $2.180 risen by 15.34%
- Scheme Booklet registered with ASIC 26 Jun 2024 1:53PM $1.905 $2.180 risen by 14.44%
- Court approval of Scheme Booklet and convening of Meeting 25 Jun 2024 2:20PM $1.895 $2.180 risen by 15.04%
- Trading Update - correction of typographical error 24 Jun 2024 9:59AM $1.900 $2.180 risen by 14.74%
- Trading Update - EBITDA guidance confirmed 24 Jun 2024 9:15AM $1.900 $2.180 risen by 14.74%
- Notification of cessation of securities - PSQ 20 Jun 2024 5:43PM n/a $2.180 n/a
- MoU with nib Health Funds to expand dental offering 19 Jun 2024 8:47AM $1.890 $2.180 risen by 15.34%
- TOV: PSQ - Declaration of Unacceptable Circumstances 18 Jun 2024 6:41PM $1.890 $2.180 risen by 15.34%
- Notification regarding unquoted securities - PSQ 17 Jun 2024 5:23PM $1.890 $2.180 risen by 15.34%
- PSQ Panel Receives Application 17 May 2024 5:05PM $1.900 $2.180 risen by 14.74%
- Update on conditions to Scheme Implementation Deed with NDC 13 May 2024 8:15AM $1.900 $2.180 risen by 14.74%
- Notification regarding unquoted securities - PSQ 9 May 2024 5:12PM $1.895 $2.180 risen by 15.04%
- Ceasing to be a substantial holder 8 May 2024 5:12PM $1.910 $2.180 risen by 14.14%

151 - 175 of 556 results

Page 7 of 23

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.